CohBar Company
Biotechnology company founded in 2007 by scientists including David Sinclair and Nir Barzilai. Based in Menlo Park, California, CohBar develops therapeutics derived from mitochondria-encoded peptides (MDPs). Its pipeline addresses metabolic dysfunction, fibrosis, and immune-related diseases by modulating mitochondrial pathways of aging. (cohbar.com)
Founded Date:
2007
Number Of Exists:
N/A
Estimated Revenue:
No public info
Headquarters:
1455 Adams Drive, Suite 2050, Menlo Park, California, 94025, United States